Search Results
61 items found for "Multiple myeloma"
- Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
GPCRs in Oncology and Immunology Comparison of infectious complications with BCMA-directed therapies in multiple myeloma Published date May 31, 2024 Abstract "B-cell-maturation-antigen (BCMA)-directed therapies are highly active for multiple myeloma, but infections are emerging as a major challenge.
- The binding mechanism of an anti-multiple myeloma antibody to the human GPRC5D homodimer
< GPCR News < GPCRs in Oncology and Immunology The binding mechanism of an anti-multiple myeloma antibody Its high expression on the surface of multiple myeloma cells has rendered it an attractive target for GPCR but also hold the potential to advance drug development targeting GPRC5D for the treatment of multiple myeloma."
- Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma
Immunology Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma Published date August 22, 2024 Abstract "Multiple myeloma (MM) is a complex hematological malignancy Authors Jihong Jeong, Junhyeon Park, Geun Young Mo, Jinwoo Shin, Yunje Cho Tags GPRC5D , Multiple myeloma
- Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
Oncology and Immunology Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma the astonishing outcomes after chimeric antigen receptor (CAR) T-cell therapy for relapsed refractory multiple myeloma (RRMM), most patients eventually relapse.
- Respiratory infections predominate after day 100 following B-cell maturation antigen-directed CAR T-cell therapy
investigational autologous BCMA CAR T-cell products at the recommended phase 2 dose) for relapsed/refractory multiple myeloma between November 2016 and May 2022.
- Classified News | Dr. GPCR Ecosystem
Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy Read More November 26, 2024 More December 5, 2024 Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma
- The orphan G protein-coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor
GPCR News < GPCRs in Oncology and Immunology The orphan G protein-coupled receptor 141 expressed in myeloid High GPR141 messenger RNA levels were expressed in myeloid-lineage cells, including neutrophils (CD11b Gpr141 -/- mice, which we independently generated, displayed almost no abnormalities in myeloid cell exacerbated disease conditions of experimental autoimmune encephalomyelitis, an autoimmune disease model for multiple 141 , autoimmune disease , dendritic cells , experimental autoimmune encephalomyelitis , monocytes , myeloid
- Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia
Oncology and Immunology Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid November 1, 2022 Abstract Blocked cellular differentiation is a critical pathologic hallmark of acute myeloid differentiation of AML both in vitro and in vivo, indicating that GPR132 is a potential trigger of myeloid this study demonstrated that activation of orphan GPR132 represents a potential strategy for inducing myeloid
- Ep 65 with Dr. Sudarshan Rajagopal
The chemokine system is relatively unique in having multiple receptors and multiple ligands that display
- Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes
state, while apo-ACKR3 shows little conformational preference and high transition probabilities among multiple Multiple active-like ACKR3 conformations are populated in response to agonists, compared to the single
- Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia
< GPCR News < GPCRs in Oncology and Immunology Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia Published date June 14, 2024 Abstract " Purpose: The inherent genetic heterogeneity of acute myeloid
- S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia
of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia Published date July 1, 2024 Abstract "Imatinib (IM), a breakthrough in chronic myeloid leukemia
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia Published date November 1, 2023 Abstract "PLK1 is overexpressed in acute myeloid leukemia (
- Ep 124 with Gáspár Pándy-Szekeres
creating an automated chimeric homology modeling pipeline for GPCRs and since have branched out to multiple
- Ep 123 with Dr. Lukas Grätz
creating an automated chimeric homology modeling pipeline for GPCRs and since have branched out to multiple
- Ep 111 with Chloe Hicks
been an undergraduate student member in the Rajagopal Lab since January 2021 and has contributed to multiple
- Using food perception and bioamine signaling networks to slow aging
The lab works with multiple models, including Caenorhabditis elegans, in vitro tissue culture, and mice
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Syndrome Alex Torrelli-Diljohn GPR124 Mediates Adhesion Of Leukemic Stem Cells To Their Niche And Leads To Myeloid at Birmingham LinkedIn GPR124 Mediates Adhesion Of Leukemic Stem Cells To Their Niche And Leads To Myeloid these studies highlight the possibility that tissue expression of single aGPCRs is likely comprised of multiple Detection of transcripts that do, and do not, contain multiple variable regions suggests expression of multiple mRNAs in specific cells.
- Ep 45 with Dr Ralf Jockers
He discovered multiple rare and loss-of-function variants of the MT2 melatonin receptors that are associated
- Chemokine Cxcl1-Cxcl2 heterodimer is a potent neutrophil chemoattractant
chemoattractant Published date November 24, 2023 Abstract "Microbial infection is characterized by release of multiple
- Itaconate in host inflammation and defense
Itaconate (ITA) rapidly accumulates to high levels in myeloid cells under infectious and sterile inflammatory
- Ep 70 with Dr. Stephen Ferguson
He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for
- Ep 32 with Dr. Chris Tate
GPCR pharmacology through structure determination of the β1-adrenoceptor and adenosine A2A receptor in multiple
- Ep 103 with Dr Kathleen Caron
Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes
- Ep 143 with Dr Davide Calebiro
He has served on multiple panels and committees, including the ENDO Annual Meeting Steering Committee
- CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
This pathway is implicated in mechanisms related to many diseases, such as cancer, psoriasis, multiple
- Ep 53 with Dr. Timo De Groof
Moreover, he is closely involved in multiple projects where he focuses on the generation of nanobodies
- Ep 95 with Chris Langmead
an acknowledged expert in drug discovery, particularly in the field of psychiatry, where he has led multiple